CLINICAL_TRIALS
trial_result
· 2016-04-13
Clinical Trial Update: Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy [Phase 3]
Summary
A Phase 3 clinical trial assessing the safety and tolerability of intravenous brivaracetam as adjunctive therapy for epilepsy has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2016-04-13